345 results
8-K
EX-99.2
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
termination of the Sanofi-Pasteur MSD joint venture, partially offset by royalty income.
(2) Amounts primarily include employee separation costs
8-K
EX-99.1
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
was due to devaluation of Argentine peso, which was largely offset by inflation-related price increases, consistent with practice in that market … .
Pharmaceutical
Increase driven by growth in oncology and vaccines, partially offset by a decline in diabetes.
KEYTRUDA
Growth driven by increased global
S-3ASR
MRK
Merck & Co Inc
19 Mar 24
Automatic shelf registration
4:26pm
if a purchase or sale order is used to offset another Plan order. Merck expects that generally all Plan purchases and sales will be effected in open market
8-K
EX-99.1
zn9fr
1 Feb 24
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
6:39am
8-K
EX-99.2
ruwr4yx63r1ckae84sv
1 Feb 24
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
6:39am
8-K
EX-99.1
e26um7 1q1ct3
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
8-K
EX-99.1
0dgx43pyn8usu
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
424B5
qeuzdktrrrd4a9
10 May 23
Prospectus supplement for primary offering
4:27pm
424B5
4czyi3ezhraj60yivexf
8 May 23
Prospectus supplement for primary offering
8:17am
8-K
EX-99.1
z8mrni288x15
27 Apr 23
Merck Announces First-Quarter 2023 Financial Results
6:43am
8-K
EX-99.2
pqc2mi25xvbkupqssmgl
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
8-K
EX-99.1
erjo l48c0kowi03050h
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am